Cost-Effectiveness Analysis of Peginterferon Beta-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy: Results of an Updated Analysis. Farmeconomia. Health Economics and Therapeutic Pathways, [S. l.], v. 19, n. 1, 2018. DOI: 10.7175/fe.v19i1.1385. Disponível em: https://journals.seedstm.com/index.php/FE/article/view/1385. Acesso em: 28 dec. 2025.